SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-063806
Filing Date
2023-08-07
Accepted
2023-08-07 06:40:38
Documents
28
Period of Report
2023-08-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182964-8k_nektar.htm   iXBRL 8-K 28683
2 SLIDES TITLED "REZPEGALDESLEUKIN (REZPEG) CORRECTED PHASE 1B DATASET FOR STUDIES ea182964ex99-1_nektar.htm EX-99.1 12594
3 PRESS RELEASE TITLED "NEKTAR ANNOUNCES PROMISING NEW AND CORRECTED REZPEGALDESLE ea182964ex99-2_nektar.htm EX-99.2 40255
4 GRAPHIC ex99-1_001.jpg GRAPHIC 498864
5 GRAPHIC ex99-1_002.jpg GRAPHIC 536713
6 GRAPHIC ex99-1_003.jpg GRAPHIC 911062
7 GRAPHIC ex99-1_004.jpg GRAPHIC 604511
8 GRAPHIC ex99-1_005.jpg GRAPHIC 358199
9 GRAPHIC ex99-1_006.jpg GRAPHIC 656174
10 GRAPHIC ex99-1_007.jpg GRAPHIC 494152
11 GRAPHIC ex99-1_008.jpg GRAPHIC 995020
12 GRAPHIC ex99-1_009.jpg GRAPHIC 251309
13 GRAPHIC ex99-1_010.jpg GRAPHIC 292575
14 GRAPHIC ex99-1_011.jpg GRAPHIC 431915
15 GRAPHIC ex99-1_012.jpg GRAPHIC 516799
16 GRAPHIC ex99-1_013.jpg GRAPHIC 623251
17 GRAPHIC ex99-1_014.jpg GRAPHIC 727679
  Complete submission text file 0001213900-23-063806.txt   11139448

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE nktr-20230807.xsd EX-101.SCH 3009
19 XBRL LABEL FILE nktr-20230807_lab.xml EX-101.LAB 34240
20 XBRL PRESENTATION FILE nktr-20230807_pre.xml EX-101.PRE 22355
22 EXTRACTED XBRL INSTANCE DOCUMENT ea182964-8k_nektar_htm.xml XML 3213
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 231145542
SIC: 2834 Pharmaceutical Preparations